AR036533A1 - Compuestos agonistas de retinoides de alquil urea, su utilizacion, composiciones farmaceuticas que los comprenden y medicamentos basados en dichos compuestos - Google Patents
Compuestos agonistas de retinoides de alquil urea, su utilizacion, composiciones farmaceuticas que los comprenden y medicamentos basados en dichos compuestosInfo
- Publication number
- AR036533A1 AR036533A1 ARP020103490A ARP020103490A AR036533A1 AR 036533 A1 AR036533 A1 AR 036533A1 AR P020103490 A ARP020103490 A AR P020103490A AR P020103490 A ARP020103490 A AR P020103490A AR 036533 A1 AR036533 A1 AR 036533A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- compounds
- cycloalkyl
- hydrogen
- urea
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Compuestos agonistas de retinoides de alquil urea de acuerdo con la fórmula estructural (1) o un hidrato, un solvato o una sal de los mismos, donde: n es un entero de 0 a 2; X es S, O ó NR3R4; R3 y R4 son independientemente hidrógeno, alquilo, arilo, arilalquilo, cicloalquilo o cicloalquil-alquilo, o junto con el átomo de nitrógeno al cual están unidos forman un anillo heterociclilo; Y es -OR5, -SR5 ó -NR6R7; R5 es hidrógeno, alquilo, arilo, arilalquilo, cicloalquilo o cicloalquil-alquilo; R6 y R7 son independientemente hidrógeno, alquilo, arilo, arilalquilo, cicloalquilo o cicloalquil-alquilo o junto con el átomo de nitrógeno al cual están unidos forman un anillo heterociclilo; R1 es alquilo C2-8; R2 es hidrógeno, alquilo, hidroxi u oxo; y R9 es hidrógeno, alquilo, haloalquilo, halo, ciano, nitro o alcoxi. Su utilización, composiciones farmacéuticas que los comprenden y medicamentos basados en los compuestos de fórmula (1). Los compuestos de fórmula (1) sal, solvato o hidrato de los mismos, son útiles especialmente para el tratamiento de enfisema, cáncer o trastornos dermatológicos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32296301P | 2001-09-18 | 2001-09-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR036533A1 true AR036533A1 (es) | 2004-09-15 |
Family
ID=33130243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP020103490A AR036533A1 (es) | 2001-09-18 | 2002-09-16 | Compuestos agonistas de retinoides de alquil urea, su utilizacion, composiciones farmaceuticas que los comprenden y medicamentos basados en dichos compuestos |
Country Status (13)
Country | Link |
---|---|
US (1) | US6844466B2 (es) |
EP (1) | EP1430024A1 (es) |
JP (1) | JP4421293B2 (es) |
KR (1) | KR100896550B1 (es) |
CN (1) | CN1283621C (es) |
AR (1) | AR036533A1 (es) |
AU (1) | AU2002329276B2 (es) |
BR (1) | BR0212583A (es) |
CA (1) | CA2460693C (es) |
MX (1) | MXPA04002590A (es) |
PL (1) | PL370361A1 (es) |
RU (1) | RU2299877C2 (es) |
WO (1) | WO2003024921A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2004251712A1 (en) * | 2003-06-23 | 2005-01-06 | Auspex Pharmaceuticals, Inc. | Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders |
WO2005108338A1 (en) * | 2004-05-03 | 2005-11-17 | Auspex Pharmaceuticals | Novel therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders |
WO2006104826A2 (en) * | 2005-03-30 | 2006-10-05 | Merck & Co., Inc. | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
TW200821284A (en) * | 2006-10-03 | 2008-05-16 | Merck & Co Inc | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
WO2012030919A2 (en) | 2010-09-01 | 2012-03-08 | Thomas Jefferson University | Composition and method for muscle repair and regeneration |
KR102173932B1 (ko) | 2012-11-08 | 2020-11-04 | 고쿠리츠다이가쿠호우진 야마구치 다이가쿠 | 각결막 장해의 치료제 |
KR101426197B1 (ko) * | 2013-02-20 | 2014-08-01 | 여윤영 | 주먹밥틀 |
MX362239B (es) | 2013-05-22 | 2019-01-09 | Univ Yamaguchi | Uso del a´cido (e)-4-(2-{3-[ (1h-pirazol-1-il)metil]-5,5,8,8- tetrametil-5,6,7,8-tetrahidronaftalen-2-il}vinil)benzoico en el tratamiento de trastornos retinocoroidales. |
CN105294567B (zh) * | 2015-10-29 | 2018-10-09 | 湖北新烯王生物科技有限公司 | 取代的3-氟苯基甲醇类化合物、药物组合物及用途 |
IL263440B (en) | 2016-06-08 | 2022-09-01 | Clementia Pharmaceuticals Inc | Methods for the treatment of heterotopic aggravation |
US10980778B2 (en) | 2016-11-16 | 2021-04-20 | Clementia Pharmaceuticals Inc. | Methods for treating multiple osteochondroma (MO) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU87821A1 (fr) | 1990-10-12 | 1992-05-25 | Cird Galderma | Composes bi-aromatiques,et leur utilisation en medecine humaine et veterinaire et en cosmetique |
US6093742A (en) | 1997-06-27 | 2000-07-25 | Vertex Pharmaceuticals, Inc. | Inhibitors of p38 |
JO2178B1 (en) * | 1999-10-19 | 2003-04-23 | اف . هوفمان لاروش ايه جي | Treatment of invasive diseases, using selected anti-PAR materials |
-
2002
- 2002-09-11 RU RU2004111787/04A patent/RU2299877C2/ru not_active IP Right Cessation
- 2002-09-11 CA CA2460693A patent/CA2460693C/en not_active Expired - Fee Related
- 2002-09-11 JP JP2003528769A patent/JP4421293B2/ja not_active Expired - Fee Related
- 2002-09-11 AU AU2002329276A patent/AU2002329276B2/en not_active Ceased
- 2002-09-11 PL PL02370361A patent/PL370361A1/xx not_active IP Right Cessation
- 2002-09-11 CN CNB028181522A patent/CN1283621C/zh not_active Expired - Fee Related
- 2002-09-11 WO PCT/EP2002/010179 patent/WO2003024921A1/en active Application Filing
- 2002-09-11 KR KR1020047003931A patent/KR100896550B1/ko not_active IP Right Cessation
- 2002-09-11 BR BR0212583-8A patent/BR0212583A/pt not_active Application Discontinuation
- 2002-09-11 MX MXPA04002590A patent/MXPA04002590A/es active IP Right Grant
- 2002-09-11 EP EP02764881A patent/EP1430024A1/en not_active Withdrawn
- 2002-09-16 AR ARP020103490A patent/AR036533A1/es unknown
- 2002-09-17 US US10/245,133 patent/US6844466B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2460693A1 (en) | 2003-03-27 |
MXPA04002590A (es) | 2004-06-18 |
JP2005505571A (ja) | 2005-02-24 |
US20030158226A1 (en) | 2003-08-21 |
RU2004111787A (ru) | 2005-10-20 |
WO2003024921A1 (en) | 2003-03-27 |
BR0212583A (pt) | 2004-10-13 |
KR100896550B1 (ko) | 2009-05-07 |
JP4421293B2 (ja) | 2010-02-24 |
RU2299877C2 (ru) | 2007-05-27 |
CA2460693C (en) | 2010-12-07 |
KR20040035809A (ko) | 2004-04-29 |
AU2002329276B2 (en) | 2008-04-24 |
CN1555359A (zh) | 2004-12-15 |
EP1430024A1 (en) | 2004-06-23 |
CN1283621C (zh) | 2006-11-08 |
PL370361A1 (en) | 2005-05-16 |
US6844466B2 (en) | 2005-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60335869D1 (de) | 1h-benzo(f)indazol-5-yl-derivate als selektive glucocorticoid-rezeptor-modulatoren | |
AR060545A1 (es) | Compuestos de benzoaxol y benzotiazol 6-0- sustituidos y metodos de inhibicion de la senalizacion de csf-1r. composiciones farmaceuticas | |
AR036659A1 (es) | Compuestos derivados de fenil-piperazina, fenil-piperidina y fenil-tetrahidropiridina como inhibidores de la reabsorcion de la serotonina, una composicion farmaceutica y utilizacion de los mismos para la preparacion de medicamentos | |
AR032679A1 (es) | Derivados del acido isoftalico como inhibidores de metaloproteinasas de la matriz | |
CO5550421A2 (es) | Derivados de indol utiles para el tratamiento de enfermeda- des | |
PA8575401A1 (es) | Derivados de heteroarilamida benzocondensada de tienopiridinas utiles como agentes terapeuticos, composiciones farmaceuticas que incluyen a los mismos y metrodos para su uso | |
ECSP034691A (es) | Inhibidores de piridina de metaloproteinasas de la matriz | |
CO5251381A1 (es) | Derivados de adamantano, un proceso para su preparacion y composiciones farmaceuticas que los contienen | |
AR036533A1 (es) | Compuestos agonistas de retinoides de alquil urea, su utilizacion, composiciones farmaceuticas que los comprenden y medicamentos basados en dichos compuestos | |
DE69522945D1 (de) | Verbindungen, die als antiproliferative mittel und als garft inhibitoren verwendbar sind | |
CA2497868A1 (en) | Heterocyclic compounds | |
ATE297910T1 (de) | Retinoid x rezeptormodulatoren | |
ATE490253T1 (de) | Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen | |
DK1506203T3 (da) | Syntese af epothiloner, mellemprodukter deraf, analoger deraf og anvendelser deraf | |
ATE280763T1 (de) | Matrix-metalloproteinase-hemmer | |
AR066972A1 (es) | Derivados azapeptidicos | |
CO5690551A2 (es) | Derivados de tetrazol y metodos para el tratamiento con los mismos de trastornos relacionados con el metabolismo | |
DE60305484D1 (de) | Verbindungen und deren verwendung als 5-ht inhibitore | |
NO20071321L (no) | Anti-inflammatoriske midler | |
AR054707A1 (es) | Derivados de octahidropirrolo 3,4-c pirrol, un procedimiento para su preparacion, una composicion farmaceutica y uso del compuesto para la fabricacion de un medicamento | |
DE60014394D1 (de) | Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha | |
DE602004026558D1 (de) | Selektive nichtsteroidale glucocorticoid-rezeptor- modulatoren | |
MY139228A (en) | Imidazolinylmethyl aralkylsulfonamides | |
AR036532A1 (es) | Compuestos agonistas de retinoides de urea sustituidos, su uso, composiciones farmaceuticas que los comprenden y medicamentos basados en dichos compuestos | |
ATE398614T1 (de) | Triazolverbindungen und ihre therapeutische verwendung |